Structural Heart Masterclass: Mitral Tricuspid Valve | Recorded at the AATS 105th Annual Meeting
This session included the following presentations:
- TMVR updates and Evolution: From Neanderthal to Caveman to What's Next?
- Clinical Trials between TEER and MV Repair: What does Equipoise Really Mean?
- Panel Discussion and Case 1: DMR In an Intermediate Risk PT with Some Calcium
- Role of Surgeon in Mitral-Tricuspid Structural Procedures
- Complex Valve Scenarios - How Do We Evaluate What is Best for Patients?
- Do We Need a Trial of TTVR/r vs. Tricuspid Valve Surgery? - How to Move Forward with Lower Risk TR Patients
Purpose (Desired Learning Outcome)
The Purpose (Desired Learning Outcome) for this course will be available soon.
ACCME Accreditation Statement
The American Association for Thoracic Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Association for Thoracic Surgery designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Commercial Support
The AATS received commercial support for the 105th Annual Meeting from:
- Abbott Medtronic
- Merck & Co. Inc.
- Olympus Regeneron
- W.L. Gore & Associates
- Boston Scientific
Available Credit
- 2.00 Participation